Erectile dysfunction and its management in patients with diabetes mellitus.

Item

http://www.wikidata.org/entity/Q38615555

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Erectile dysfunction and its management in patients with diabetes mellitus.

@en

type

Item

label

Erectile dysfunction and its management in patients with diabetes mellitus.

@en

prefLabel

Erectile dysfunction and its management in patients with diabetes mellitus.

@en

P1476

Erectile dysfunction and its management in patients with diabetes mellitus.

@en

P2093

Andrea Lenzi

http://www.w3.org/2001/XMLSchema#string

Chiara Di Emidio

http://www.w3.org/2001/XMLSchema#string

Daniele Gianfrilli

http://www.w3.org/2001/XMLSchema#string

Paolo Pozzilli

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme

The alliance of mesenchymal stem cells, bone, and diabetes

High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients

Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

Erectile dysfunction in diabetes mellitus.

Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials.

Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.

Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO/SIRT1/PGC-1α signaling.

P2888

s11154-015-9321-4

P31

scholarly article

P356

10.1007/S11154-015-9321-4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1013356103

http://www.w3.org/2001/XMLSchema#string

P698

26497842

http://www.w3.org/2001/XMLSchema#string